Krka, d. d. (WSE:KRK)
Poland
· Delayed Price · Currency is PLN 866.00
+2.00 (0.23%)
At close: Dec 5, 2025
Krka, d. d. Revenue
Krka, d. d. had revenue of 485.49M EUR in the quarter ending September 30, 2025, with 8.07% growth. This brings the company's revenue in the last twelve months to 2.01B, up 5.70% year-over-year. In the year 2024, Krka, d. d. had annual revenue of 1.91B with 5.71% growth.
Revenue (ttm)
2.01B EUR
Revenue Growth
+5.70%
P/S Ratio
3.04
Revenue / Employee
177.65K EUR
Employees
11,308
Market Cap
26.04B PLN
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.91B | 103.15M | 5.71% |
| Dec 31, 2023 | 1.81B | 88.94M | 5.18% |
| Dec 31, 2022 | 1.72B | 151.65M | 9.69% |
| Dec 31, 2021 | 1.57B | 30.86M | 2.01% |
| Dec 31, 2020 | 1.53B | 41.53M | 2.78% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Diagnostyka | 2.30B |
| NEUCA | 13.34B |
| Synektik Spólka Akcyjna | 623.20M |
| Voxel | 568.83M |
| Celon Pharma | 225.60M |
| Selvita | 373.90M |
| Ryvu Therapeutics | 90.41M |
| Centrum Medyczne ENEL-MED | 820.59M |